Medix Infusion is a technology-enabled, healthcare platform, highly focused on improving patient care.
Medix Infusion has raised $35.0M in total funding. The most recent round was Series B. The last funding was announced in January 2023.
Medix Infusion's investors include Noro-Moseley Partners, Live Oak Bank, Echo Health Ventures, Pittco Capital Partners.
Medix Infusion is headquartered in Addison, United States.
Medix Infusion is a technology-enabled, healthcare platform, highly focused on improving patient care.
Medix Infusion is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Medix Infusion — Funding & Investors." VCBacked, January 9, 2023, https://www.vcbacked.co/company/medix-infusion. Accessed August 15, 2026.
VCBacked. (2023). Medix Infusion — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/medix-infusion
{{cite web |title=Medix Infusion — Funding & Investors |url=https://www.vcbacked.co/company/medix-infusion |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated